Literature DB >> 23929771

The pathogenesis of lupus nephritis.

Maciej Lech1, Hans-Joachim Anders.   

Abstract

Lupus nephritis is an immune complex GN that develops as a frequent complication of SLE. The pathogenesis of lupus nephritis involves a variety of pathogenic mechanisms. The extrarenal etiology of systemic lupus is based on multiple combinations of genetic variants that compromise those mechanisms normally assuring immune tolerance to nuclear autoantigens. This loss of tolerance becomes clinically detectable by the presence of antinuclear antibodies. In addition, nucleic acids released from netting or apoptotic neutrophils activate innate and adaptive immunity via viral nucleic acid-specific Toll-like receptors. Therefore, many clinical manifestations of systemic lupus resemble those of viral infection. In lupus, endogenous nuclear particles trigger IFN-α signaling just like viral particles during viral infection. As such, dendritic cells, T helper cells, B cells, and plasma cells all contribute to the aberrant polyclonal autoimmunity. The intrarenal etiology of lupus nephritis involves antibody binding to multiple intrarenal autoantigens rather than the deposition of circulating immune complexes. Tertiary lymphoid tissue formation and local antibody production add to intrarenal complement activation as renal immunopathology progresses. Here we provide an update on the pathogenic mechanisms that lead to lupus nephritis and provide the rationale for the latest and novel treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23929771      PMCID: PMC3752952          DOI: 10.1681/ASN.2013010026

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  108 in total

1.  Differential binding of cross-reactive anti-DNA antibodies to mesangial cells: the role of alpha-actinin.

Authors:  Zeguo Zhao; Bisram Deocharan; Philipp E Scherer; Laurie J Ozelius; Chaim Putterman
Journal:  J Immunol       Date:  2006-06-15       Impact factor: 5.422

2.  U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7.

Authors:  Emina Savarese; Ohk-wha Chae; Simon Trowitzsch; Gert Weber; Berthold Kastner; Shizuo Akira; Hermann Wagner; Roland M Schmid; Stefan Bauer; Anne Krug
Journal:  Blood       Date:  2005-12-20       Impact factor: 22.113

3.  Lack of SIGIRR/TIR8 aggravates hydrocarbon oil-induced lupus nephritis.

Authors:  Maciej Lech; Veronika Skuginna; Onkar P Kulkarni; Jing Gong; Tiandi Wei; Robert W Stark; Cecilia Garlanda; Alberto Mantovani; Hans-Joachim Anders
Journal:  J Pathol       Date:  2010-04       Impact factor: 7.996

Review 4.  Thirty years of cyclophosphamide: assessing the evidence.

Authors:  F Houssiau
Journal:  Lupus       Date:  2007       Impact factor: 2.911

5.  Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.

Authors:  Guillermo Pérez de Lema; Holger Maier; Tobias J Franz; Maríia Escribese; Silvia Chilla; Stephan Segerer; Natalia Camarasa; Holger Schmid; Bernhard Banas; Svetoslav Kalaydjiev; Dirk H Busch; Klaus Pfeffer; Francisco Mampaso; Detlef Schlöndorff; Bruno Luckow
Journal:  J Am Soc Nephrol       Date:  2005-11-02       Impact factor: 10.121

6.  Hydroxychloroquine in lupus pregnancy.

Authors:  Megan E B Clowse; Laurence Magder; Frank Witter; Michelle Petri
Journal:  Arthritis Rheum       Date:  2006-11

7.  Pure anti-dsDNA mAbs need chromatin structures to promote glomerular mesangial deposits in BALB/c mice.

Authors:  Kristin Andreassen Fenton; Berit Tømmerås; Tony Norman Marion; Ole Petter Rekvig
Journal:  Autoimmunity       Date:  2010-03       Impact factor: 2.815

8.  Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus.

Authors:  Rahul D Pawar; Allam Ramanjaneyulu; Onkar P Kulkarni; Maciej Lech; Stephan Segerer; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2007-04-25       Impact factor: 10.121

Review 9.  Multistep pathogenesis of autoimmune disease.

Authors:  Christopher C Goodnow
Journal:  Cell       Date:  2007-07-13       Impact factor: 41.582

10.  Regulation of leukocyte recruitment by the long pentraxin PTX3.

Authors:  Livija Deban; Remo Castro Russo; Marina Sironi; Federica Moalli; Margherita Scanziani; Vanessa Zambelli; Ivan Cuccovillo; Antonio Bastone; Marco Gobbi; Sonia Valentino; Andrea Doni; Cecilia Garlanda; Silvio Danese; Giovanni Salvatori; Marica Sassano; Virgilio Evangelista; Barbara Rossi; Elena Zenaro; Gabriela Constantin; Carlo Laudanna; Barbara Bottazzi; Alberto Mantovani
Journal:  Nat Immunol       Date:  2010-03-07       Impact factor: 25.606

View more
  133 in total

1.  Factor H uptake regulates intracellular C3 activation during apoptosis and decreases the inflammatory potential of nucleosomes.

Authors:  M Martin; J Leffler; K I Smoląg; J Mytych; A Björk; L D Chaves; J J Alexander; R J Quigg; A M Blom
Journal:  Cell Death Differ       Date:  2016-01-15       Impact factor: 15.828

2.  Brief Report: Tubulointerstitial Damage in Lupus Nephritis: A Comparison of the Factors Associated With Tubulointerstitial Inflammation and Renal Scarring.

Authors:  Alejandra Londoño Jimenez; Wenzhu B Mowrey; Chaim Putterman; Jill Buyon; Beatrice Goilav; Anna Broder
Journal:  Arthritis Rheumatol       Date:  2018-09-24       Impact factor: 10.995

3.  Erythropoietin Treatment Ameliorates Lupus Nephritis of MRL/lpr Mice.

Authors:  Zeming Zhang; Dongmei Liu; Xiaoli Zhang; Xiaofei Wang
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

4.  Abrogated AID Function Prolongs Survival and Diminishes Renal Pathology in the BXSB Mouse Model of Systemic Lupus Erythematosus.

Authors:  Jing Zhu; Alayna N Hay; Ashley A Potter; Madison W Richwine; Thomas Sproule; Tanya LeRoith; John Wilson; Muneer G Hasham; Derry C Roopenian; Caroline M Leeth
Journal:  J Immunol       Date:  2020-01-27       Impact factor: 5.422

Review 5.  Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis.

Authors:  Hans-Joachim Anders; Liliana Schaefer
Journal:  J Am Soc Nephrol       Date:  2014-04-24       Impact factor: 10.121

Review 6.  [Lupus nephritis].

Authors:  J Schreiber; U Eisenberger; K de Groot
Journal:  Internist (Berl)       Date:  2019-05       Impact factor: 0.743

7.  C3 glomerulonephritis and autoimmune disease: more than a fortuitous association?

Authors:  Mariam P Alexander; Fernando C Fervenza; An S De Vriese; Richard J H Smith; Samih H Nasr; Lynn D Cornell; Loren P Herrera Hernandez; Yuzhou Zhang; Sanjeev Sethi
Journal:  J Nephrol       Date:  2015-07-18       Impact factor: 3.902

Review 8.  Design and application of single-cell RNA sequencing to study kidney immune cells in lupus nephritis.

Authors:  Deepak A Rao; Arnon Arazi; David Wofsy; Betty Diamond
Journal:  Nat Rev Nephrol       Date:  2019-12-18       Impact factor: 28.314

Review 9.  Redefining lupus nephritis: clinical implications of pathophysiologic subtypes.

Authors:  Feng Yu; Mark Haas; Richard Glassock; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2017-07-03       Impact factor: 28.314

10.  E3 ligase FBXW7 aggravates TMPD-induced systemic lupus erythematosus by promoting cell apoptosis.

Authors:  Zhenlu Chong; Chunjing Bao; Jia He; Tianxiao Chen; Lijia Zhong; Gaopeng Li; Huanle Li; Lutong Fang; Yinjing Song; Guoxiang Fu; Xuyan Yang; Lihua Lai; Yang Liu; Qingqing Wang
Journal:  Cell Mol Immunol       Date:  2018-10-01       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.